🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
14/12/2018 0,5248 USD
14/09/2018 0,4580 USD
14/06/2018 0,4580 USD
14/03/2018 0,4580 USD
14/12/2017 0,4580 USD
14/09/2017 0,4485 USD
13/06/2017 0,4485 USD
13/03/2017 0,4485 USD
13/12/2016 0,4485 USD
13/09/2016 0,4389 USD
13/06/2016 0,4389 USD
11/03/2016 0,4389 USD
11/12/2015 0,4389 USD
11/09/2015 0,4294 USD
11/06/2015 0,4294 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/09/2015 49,73 50,31 49,61 49,94 +0,48% 1,42% 9.213.387
11/09/2015 49,82 50,05 49,34 49,70 -1,19% 1,42% 12.671.158
10/09/2015 49,64 50,76 49,48 50,31 +1,52% 2,58% 14.740.539
09/09/2015 50,77 50,89 49,44 49,55 -1,44% 2,86% 11.650.302
08/09/2015 50,58 50,59 49,81 50,28 +2,13% 1,55% 15.679.233
04/09/2015 49,71 49,85 48,84 49,23 -2,01% 2,03% 15.186.882
03/09/2015 50,83 51,10 50,19 50,24 -0,62% 1,78% 12.732.257
02/09/2015 50,73 50,83 49,95 50,55 +0,86% 1,73% 13.761.078
01/09/2015 50,25 50,79 49,81 50,12 -2,45% 1,96% 16.503.275
31/08/2015 52,60 52,77 51,16 51,38 -2,75% 3,05% 13.537.121
28/08/2015 52,27 52,87 52,09 52,83 +0,76% 1,50% 13.411.256
27/08/2015 52,75 52,86 51,18 52,43 +0,97% 3,18% 16.910.109
26/08/2015 50,95 52,11 50,09 51,93 +6,35% 3,97% 23.989.978
25/08/2015 52,85 52,87 48,66 48,83 -5,22% 7,96% 23.946.590
24/08/2015 50,64 51,91 43,60 51,52 -3,19% 16,41% 26.030.853
21/08/2015 54,00 54,99 53,21 53,22 -2,07% 3,30% 18.478.860
20/08/2015 55,62 55,87 54,14 54,34 -4,54% 3,11% 24.831.731
19/08/2015 56,60 57,32 56,48 56,93 +0,00% 1,48% 8.369.642
18/08/2015 56,94 57,20 56,83 56,93 -0,08% 0,65% 7.123.675
17/08/2015 56,11 57,01 55,90 56,98 +0,90% 1,99% 6.407.158
14/08/2015 56,31 56,84 56,17 56,47 +0,34% 1,19% 9.920.787
13/08/2015 55,87 56,73 55,82 56,28 +1,24% 1,62% 11.483.146
12/08/2015 54,66 55,61 54,50 55,59 +0,87% 2,03% 7.886.514
11/08/2015 55,28 55,52 54,92 55,11 -1,11% 1,09% 7.418.058
10/08/2015 55,59 55,93 55,59 55,73 +0,76% 0,60% 5.294.915
07/08/2015 55,68 55,77 55,03 55,31 -0,79% 1,34% 10.178.595
06/08/2015 56,45 56,54 55,65 55,75 -1,13% 1,57% 7.356.646
05/08/2015 56,37 56,56 56,08 56,39 +0,68% 0,86% 5.976.325
04/08/2015 56,72 56,75 55,70 56,01 -0,59% 1,85% 7.268.718
03/08/2015 56,58 56,73 55,80 56,35 +0,15% 1,64% 7.133.736